{
    "info": {
        "nct_id": "NCT05141721",
        "official_title": "A Phase 2/3, Randomized, Open-Label Study of Maintenance GRT-C901/GRT-R902, A Neoantigen Vaccine, in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer",
        "inclusion_criteria": "* Patients with histologically confirmed metastatic colorectal cancer (CRC) who are planned for, or have received <30 days of first-line treatment in the metastatic setting with FOLFOX/bev, CAPEOX/bev, FOLFOXIRI/bev, or CAPOXIRI/bev per SOC\n* Measurable and unresectable metastatic disease according to RECIST v1.1\n* Availability of formalin-fixed paraffin-embedded (FFPE) tumor specimens.\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1\n* Patient has adequate organ function per defined criteria\n* If women of childbearing potential (WCBP), must be willing to undergo pregnancy testing and agrees to the use at least 1 highly effective contraceptive method during the study treatment period and for 150 days after last investigational study treatment.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Patients with deficient mismatch repair (dMMR) or microsatellite instability (MSI-H) phenotype\n* Patient has a known tumor mutation burden <1 non-synonymous mutations/megabase\n* Known DNA Polymerase Epsilon mutations\n* Patients with known BRAFV600E mutations\n* Bleeding disorder or history of significant bruising or bleeding following IM injections or blood draws\n* Immunosuppression anticipated at time of study treatment\n* History of allogeneic tissue/solid organ transplant\n* Active or history of autoimmune disease or immune deficiency\n* Patient with symptomatic or actively progressing central nervous system (CNS) metastases, carcinomatous meningitis, or has been treated with whole brain radiation\n* History of other cancer within 2 years with the exception of neoplasm that has undergone potentially curative therapy\n* Any severe concurrent non-cancer disease that, in the judgment of the Investigator, would make the patient inappropriate for the current study\n* Active tuberculosis or recent (<2 weeks) clinically significant infection, evidence of active hepatitis B or hepatitis C, or known history of positive test for HIV\n* History of pneumonitis requiring systemic steroids for treatment (with the exception of prior resolved in-field radiation pneumonitis)\n* Myocardial infarction within previous 3 months, unstable angina, serious uncontrolled cardiac arrhythmia, history of myocarditis, or congestive heart failure (Class III or IV).\n* Pregnant, planning to become pregnant, or nursing.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Measurable and unresectable metastatic disease according to RECIST v1.1",
            "criterions": [
                {
                    "exact_snippets": "Measurable ... metastatic disease according to RECIST v1.1",
                    "criterion": "metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "unresectability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "RECIST v1.1 definition",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Availability of formalin-fixed paraffin-embedded (FFPE) tumor specimens.",
            "criterions": [
                {
                    "exact_snippets": "Availability of formalin-fixed paraffin-embedded (FFPE) tumor specimens.",
                    "criterion": "formalin-fixed paraffin-embedded (FFPE) tumor specimens",
                    "requirements": [
                        {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patient has adequate organ function per defined criteria",
            "criterions": [
                {
                    "exact_snippets": "adequate organ function per defined criteria",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* If women of childbearing potential (WCBP), must be willing to undergo pregnancy testing and agrees to the use at least 1 highly effective contraceptive method during the study treatment period and for 150 days after last investigational study treatment.",
            "criterions": [
                {
                    "exact_snippets": "women of childbearing potential (WCBP)",
                    "criterion": "sex and reproductive status",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "reproductive status",
                            "expected_value": "of childbearing potential"
                        }
                    ]
                },
                {
                    "exact_snippets": "must be willing to undergo pregnancy testing",
                    "criterion": "willingness to undergo pregnancy testing",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "agrees to the use at least 1 highly effective contraceptive method during the study treatment period and for 150 days after last investigational study treatment",
                    "criterion": "contraceptive use",
                    "requirements": [
                        {
                            "requirement_type": "method effectiveness",
                            "expected_value": "highly effective"
                        },
                        {
                            "requirement_type": "number of methods",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "method"
                            }
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "during the study treatment period and for 150 days after last investigational study treatment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with histologically confirmed metastatic colorectal cancer (CRC) who are planned for, or have received <30 days of first-line treatment in the metastatic setting with FOLFOX/bev, CAPEOX/bev, FOLFOXIRI/bev, or CAPOXIRI/bev per SOC",
            "criterions": [
                {
                    "exact_snippets": "histologically confirmed metastatic colorectal cancer (CRC)",
                    "criterion": "metastatic colorectal cancer",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": "histology"
                        }
                    ]
                },
                {
                    "exact_snippets": "planned for, or have received <30 days of first-line treatment in the metastatic setting",
                    "criterion": "first-line treatment in the metastatic setting",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": [
                                "planned",
                                "initiated"
                            ]
                        },
                        {
                            "requirement_type": "treatment duration",
                            "expected_value": {
                                "operator": "<",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "with FOLFOX/bev, CAPEOX/bev, FOLFOXIRI/bev, or CAPOXIRI/bev per SOC",
                    "criterion": "first-line treatment regimen",
                    "requirements": [
                        {
                            "requirement_type": "regimen",
                            "expected_value": [
                                "FOLFOX/bev",
                                "CAPEOX/bev",
                                "FOLFOXIRI/bev",
                                "CAPOXIRI/bev"
                            ]
                        },
                        {
                            "requirement_type": "standard of care",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Patient with symptomatic or actively progressing central nervous system (CNS) metastases, carcinomatous meningitis, or has been treated with whole brain radiation",
            "criterions": [
                {
                    "exact_snippets": "symptomatic or actively progressing central nervous system (CNS) metastases",
                    "criterion": "central nervous system (CNS) metastases",
                    "requirements": [
                        {
                            "requirement_type": "symptom status",
                            "expected_value": "symptomatic"
                        },
                        {
                            "requirement_type": "progression status",
                            "expected_value": "actively progressing"
                        }
                    ]
                },
                {
                    "exact_snippets": "carcinomatous meningitis",
                    "criterion": "carcinomatous meningitis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "has been treated with whole brain radiation",
                    "criterion": "whole brain radiation treatment",
                    "requirements": [
                        {
                            "requirement_type": "treatment history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of allogeneic tissue/solid organ transplant",
            "criterions": [
                {
                    "exact_snippets": "History of allogeneic tissue/solid organ transplant",
                    "criterion": "allogeneic tissue/solid organ transplant",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with deficient mismatch repair (dMMR) or microsatellite instability (MSI-H) phenotype",
            "criterions": [
                {
                    "exact_snippets": "deficient mismatch repair (dMMR)",
                    "criterion": "mismatch repair status",
                    "requirements": [
                        {
                            "requirement_type": "deficiency",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "microsatellite instability (MSI-H) phenotype",
                    "criterion": "microsatellite instability status",
                    "requirements": [
                        {
                            "requirement_type": "phenotype",
                            "expected_value": "MSI-H"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patient has a known tumor mutation burden <1 non-synonymous mutations/megabase",
            "criterions": [
                {
                    "exact_snippets": "known tumor mutation burden <1 non-synonymous mutations/megabase",
                    "criterion": "tumor mutation burden",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1,
                                "unit": "non-synonymous mutations/megabase"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any severe concurrent non-cancer disease that, in the judgment of the Investigator, would make the patient inappropriate for the current study",
            "criterions": [
                {
                    "exact_snippets": "Any severe concurrent non-cancer disease",
                    "criterion": "severe concurrent non-cancer disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "that, in the judgment of the Investigator, would make the patient inappropriate for the current study",
                    "criterion": "appropriateness for the current study (per Investigator judgment)",
                    "requirements": [
                        {
                            "requirement_type": "appropriateness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active or history of autoimmune disease or immune deficiency",
            "criterions": [
                {
                    "exact_snippets": "Active or history of autoimmune disease",
                    "criterion": "autoimmune disease",
                    "requirements": [
                        {
                            "requirement_type": "presence or history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "immune deficiency",
                    "criterion": "immune deficiency",
                    "requirements": [
                        {
                            "requirement_type": "presence or history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Bleeding disorder or history of significant bruising or bleeding following IM injections or blood draws",
            "criterions": [
                {
                    "exact_snippets": "Bleeding disorder",
                    "criterion": "bleeding disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of significant bruising or bleeding following IM injections or blood draws",
                    "criterion": "significant bruising or bleeding following IM injections or blood draws",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of pneumonitis requiring systemic steroids for treatment (with the exception of prior resolved in-field radiation pneumonitis)",
            "criterions": [
                {
                    "exact_snippets": "History of pneumonitis requiring systemic steroids for treatment",
                    "criterion": "history of pneumonitis requiring systemic steroids for treatment",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients with known BRAFV600E mutations",
            "criterions": [
                {
                    "exact_snippets": "known BRAFV600E mutations",
                    "criterion": "BRAFV600E mutation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "mutation_status",
                            "expected_value": "known"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Immunosuppression anticipated at time of study treatment",
            "criterions": [
                {
                    "exact_snippets": "Immunosuppression anticipated at time of study treatment",
                    "criterion": "immunosuppression",
                    "requirements": [
                        {
                            "requirement_type": "anticipated_at_time_of_study_treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnant, planning to become pregnant, or nursing.",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "planning to become pregnant",
                    "criterion": "intention to become pregnant",
                    "requirements": [
                        {
                            "requirement_type": "intention",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "nursing",
                    "criterion": "nursing status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known DNA Polymerase Epsilon mutations",
            "criterions": [
                {
                    "exact_snippets": "Known DNA Polymerase Epsilon mutations",
                    "criterion": "DNA Polymerase Epsilon mutations",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "knowledge_status",
                            "expected_value": "known"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of other cancer within 2 years with the exception of neoplasm that has undergone potentially curative therapy",
            "criterions": [
                {
                    "exact_snippets": "History of other cancer within 2 years",
                    "criterion": "history of other cancer",
                    "requirements": [
                        {
                            "requirement_type": "time since diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "exception of neoplasm that has undergone potentially curative therapy",
                    "criterion": "neoplasm that has undergone potentially curative therapy",
                    "requirements": [
                        {
                            "requirement_type": "treatment outcome",
                            "expected_value": "potentially curative therapy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Myocardial infarction within previous 3 months, unstable angina, serious uncontrolled cardiac arrhythmia, history of myocarditis, or congestive heart failure (Class III or IV).",
            "criterions": [
                {
                    "exact_snippets": "Myocardial infarction within previous 3 months",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable angina",
                    "criterion": "unstable angina",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "serious uncontrolled cardiac arrhythmia",
                    "criterion": "serious uncontrolled cardiac arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of myocarditis",
                    "criterion": "myocarditis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "congestive heart failure (Class III or IV)",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "NYHA class",
                            "expected_value": [
                                "III",
                                "IV"
                            ]
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "* Active tuberculosis or recent (<2 weeks) clinically significant infection, evidence of active hepatitis B or hepatitis C, or known history of positive test for HIV",
            "criterions": [
                {
                    "exact_snippets": "Active tuberculosis",
                    "criterion": "tuberculosis",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "recent (<2 weeks) clinically significant infection",
                    "criterion": "clinically significant infection",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<",
                                "value": 2,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "significance",
                            "expected_value": "clinically significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "evidence of active hepatitis B",
                    "criterion": "hepatitis B",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "evidence of active hepatitis C",
                    "criterion": "hepatitis C",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "known history of positive test for HIV",
                    "criterion": "HIV",
                    "requirements": [
                        {
                            "requirement_type": "history of positive test",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}